It will therefore be of great interest to examine LGR5 expression in a larger cohort of patients using immunohistochemistry to evaluate its prognostic significance, and assess its correlation with phosphorylated MEK/ERK/Akt in primary tumours. The gene discussed is AKT1; the disease is neoplasm.